31 Participants NeededMy employer runs this trial

Disfrutando for Type 2 Diabetes

(Disfrutando 2 Trial)

Recruiting at 1 trial location
ME
Overseen ByMaithe Enriquez, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Missouri-Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new approach called 'Disfrutando' to help people prevent and manage type 2 diabetes. The goal is to provide participants with tools and knowledge to better manage their condition and address social challenges that may hinder their health. The trial includes two groups: one begins the program immediately, while the other joins after a waiting period. This trial may suit individuals with higher-than-normal blood sugar levels (Hemoglobin A1C of 5.7 or higher). As an unphased trial, participants contribute to innovative research that may enhance diabetes management strategies.

What prior data suggests that the Disfrutando intervention is safe for managing Type 2 Diabetes?

Research shows that specific safety information for the treatment called Disfrutando is not available. The trial is labeled as "Not Applicable" for its phase, indicating that detailed safety data might not yet exist. However, if this treatment is being tested as a new method, it is likely considered safe enough for trials, as earlier trial phases usually focus on safety.

Specific safety data for Disfrutando is unavailable. If approved for another condition, it might suggest safety, but that information is not provided. Participants in trials are closely monitored for any side effects, and ensuring their safety is a top priority.

Prospective participants should consult the research team to understand any possible risks or side effects.12345

Why are researchers excited about this trial?

Researchers are excited about Disfrutando for type 2 diabetes because it offers a novel behavioral intervention approach. Unlike standard treatments that often rely on medications like metformin or insulin to manage blood sugar levels, Disfrutando focuses on changing lifestyle habits and behaviors. This approach could empower patients to take control of their health in a more sustainable way, potentially reducing reliance on medication and improving overall well-being.

What evidence suggests that the Disfrutando intervention might be an effective treatment for type 2 diabetes?

Research has shown that lifestyle programs like 'Disfrutando' can reduce the risk of developing type 2 diabetes by 25%. This indicates that fewer people develop diabetes when they adopt healthier daily routines. Studies also suggest that organized programs can significantly improve health by lowering blood sugar and cholesterol levels. These programs help individuals manage diabetes more effectively and enhance overall health. In this trial, participants will be divided into two groups: the Intervention Group, which will receive the 'Disfrutando' program immediately, and the Waitlist Group, which will receive the intervention after a waitlist period. While specific results for 'Disfrutando' are still being gathered, the program employs methods that have proven successful in similar programs.678910

Are You a Good Fit for This Trial?

Inclusion Criteria

My Hemoglobin A1C level is 5.7 or higher.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Disfrutando intervention, focusing on diabetes self-management and addressing social determinants of health

12 weeks
Weekly visits for 6 weeks, then at 12 weeks

Follow-up

Participants are monitored for changes in HbA1C, body weight, and self-efficacy

6 months
Visits at 12 weeks and 6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Disfrutando

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Waitlist GroupExperimental Treatment1 Intervention
Group II: Intervention GroupExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Missouri-Columbia

Lead Sponsor

Trials
387
Recruited
629,000+

Citations

1 Written Consent to Participate in a Clinical Trial Project Title

The purpose of the study is to assess the effectiveness of the 'Disfrutando' intervention in helping individuals gain knowledge ... There will be about 30 people ...

The effectiveness of lifestyle interventions on type 2 diabetes ...

Lifestyle interventions decreased the incidence risk ratio of type 2 diabetes by 25% (0·75 [95% CI 0·61 to 0·91]), and reduced the levels of ...

Effectiveness of and Implementation Strategies for 'Disfrutando'.

Effectiveness of and Implementation Strategies for 'Disfrutando'. Conditions: Type 2 Diabetes Mellitus (T2DM) Interventions: Behavioral ...

Effectiveness of a Structured 2-Year Diabetes Health ... - PMC

Results demonstrated significant improvements among DHE participants: HbA1c levels decreased by 37%, fasting glucose by 4%, total cholesterol by ...

Faculty and Postdoctoral Funded Research and Clinical ...

Effectiveness of and implementation strategies for 'Disfrutando': A tailored, bundled intervention to address type 2 diabetes mellitus in high-burden ...

Artificial Sweeteners and Risk of Type 2 Diabetes in the ... - PMC

These findings of positive associations between artificial sweetener intakes and increased T2D risk strengthen the evidence that these additives may not be safe ...

Artificial sweeteners and their implications for patients with ...

The results of the case-control/cohort studies concluded that the consumption of sweetened beverages was linked to a risk of LADA or type 2 diabetes [15] and ...

Sugar- and Artificially Sweetened Beverages Consumption ...

With each additional serving of SSB per day, the risk of developing T2D increased by 27% (RR: 1.27, 95%CI: 1.15–1.41), with high evidence of heterogeneity (I2 = ...

FDA Proposes Broad Approach for Conducting Safety ...

“By following previous FDA recommendations, sponsors have shown that new type 2 diabetes drugs do not have excess ischemic cardiovascular risk, ...

Strange Article Uncovers The Inaccurate Methods of ...

Chronic lack of sleep may contribute to the danger of type 2 diabetes, based on a small examine revealed in 2015. Healthy volunteers who slept solely 4 ...